These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8005733)

  • 1. Immunocytochemical analysis of uterine papillary serous carcinomas for estrogen and progesterone receptors.
    Umpierre SA; Burke TW; Tornos C; Ordonez N; Levenback C; Morris M
    Int J Gynecol Pathol; 1994 Apr; 13(2):127-30. PubMed ID: 8005733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uterine papillary serous carcinoma evolves via a p53-driven pathway.
    Moll UM; Chalas E; Auguste M; Meaney D; Chumas J
    Hum Pathol; 1996 Dec; 27(12):1295-300. PubMed ID: 8958301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemically estrogen receptor-negative, progesterone receptor-positive breast carcinoma. Immunocytochemical hormone receptors and prognostic factors.
    Keshgegian AA
    Arch Pathol Lab Med; 1994 Mar; 118(3):240-4. PubMed ID: 8135626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen and progesterone receptors in endometrial cancer and their prognostic relevance.
    Kleine W; Maier T; Geyer H; Pfleiderer A
    Gynecol Oncol; 1990 Jul; 38(1):59-65. PubMed ID: 2141316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma. Part I: Clinical and histologic correlations.
    Carcangiu ML; Chambers JT; Voynick IM; Pirro M; Schwartz PE
    Am J Clin Pathol; 1990 Sep; 94(3):247-54. PubMed ID: 1697729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relation between the levels of estrogen receptor and progesterone receptor and clinicopathological status in human endometrial carcinomas].
    Yi X; Yao X
    Hua Xi Yi Ke Da Xue Xue Bao; 1991 Mar; 22(1):66-9. PubMed ID: 1774041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interobserver reproducibility of immunocytochemical estrogen- and progesterone receptor status assessment in breast cancer.
    Biesterfeld S; Veuskens U; Schmitz FJ; Amo-Takyi B; Böcking A
    Anticancer Res; 1996; 16(5A):2497-500. PubMed ID: 8917341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen and progesterone receptors in breast cancer: comparison between enzyme immunoassay and computer-assisted image analysis of immunocytochemical assay.
    Cavaliere A; Bucciarelli E; Sidoni A; Bianchi G; Pietropaoli N; Ludovini V; Vitali R
    Cytometry; 1996 Sep; 26(3):204-8. PubMed ID: 8889392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Estrogen and progesterone receptors in endometrial carcinoma].
    Guo Y; Dang Q
    Zhonghua Fu Chan Ke Za Zhi; 1997 Jul; 32(7):418-21. PubMed ID: 9639729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coordinate expression of Cdc25B and ER-alpha is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas.
    Wu W; Slomovitz BM; Celestino J; Chung L; Thornton A; Lu KH
    Cancer Res; 2003 Oct; 63(19):6195-9. PubMed ID: 14559803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocytochemical assay of estrogen and progesterone receptors in fine needle aspirates from breast cancer patients.
    Nizzoli R; Bozzetti C; Savoldi L; Manotti L; Naldi N; Camisa R; Soresi AP; Guazzi A; Cocconi G
    Acta Cytol; 1994; 38(6):933-8. PubMed ID: 7992582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of PR and ER by immunocytochemistry in breast cancer. Comparison with radioligand binding methods.
    Seymour L; Meyer K; Esser J; MacPhail AP; Behr A; Bezwoda WR
    Am J Clin Pathol; 1990 Oct; 94(4 Suppl 1):S35-40. PubMed ID: 1699410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature.
    Kounelis S; Kapranos N; Kouri E; Coppola D; Papadaki H; Jones MW
    Mod Pathol; 2000 Apr; 13(4):379-88. PubMed ID: 10786803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of results of estrogen and progesterone receptor assays performed in a community hospital.
    Szakacs JG; Arroyo JG; Girgenti AJ
    Ann Clin Lab Sci; 1986; 16(4):266-73. PubMed ID: 3740795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroid receptors in carcinoma of the breast. Results of immunocytochemical and biochemical determination and their effects on short-term prognosis.
    Kommoss F; Pfisterer J; Idris T; Giese E; Sauerbrei W; Schäfer W; Thome M; Pfleiderer A
    Anal Quant Cytol Histol; 1994 Jun; 16(3):203-10. PubMed ID: 7916848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of endocrine status on biochemical and immunocytochemical estrogen and progesterone receptor assays in breast cancer patients.
    Helin HJ; Isola JJ; Helle MJ; Adlercreutz H
    Breast Cancer Res Treat; 1988 Sep; 12(1):67-73. PubMed ID: 3196886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical significance of analysis of estrogen and progesterone receptors in human uterine tissues].
    Maleeva A; Milkov V
    Akush Ginekol (Mosk); 1991 May; (5):55-7. PubMed ID: 1897675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.
    Lax SF; Pizer ES; Ronnett BM; Kurman RJ
    Hum Pathol; 1998 Jun; 29(6):551-8. PubMed ID: 9635673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancers negative for estrogen receptor but positive for progesterone receptor, a true entity?
    Kiang DT; Kollander R
    J Clin Oncol; 1987 Apr; 5(4):662-6. PubMed ID: 2435857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of c-erbB-2 protein and epidermal growth receptor in endometrial carcinomas. Correlation with clinicopathologic and sex steroid receptor status.
    Wang D; Konishi I; Koshiyama M; Mandai M; Nanbu Y; Ishikawa Y; Mori T; Fujii S
    Cancer; 1993 Nov; 72(9):2628-37. PubMed ID: 8104681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.